BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28356770)

  • 1. Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature.
    Nandikolla AG; Venugopal S; Anampa J
    Breast Cancer (Dove Med Press); 2017; 9():207-215. PubMed ID: 28356770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
    Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN
    Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
    Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
    Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
    Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
    J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Li-Fraumeni Syndrome, A Rarity Among Rarities: A Case Report and Review of Literature.
    Elremeli M; Idaewor P; Rasheed N; Saad Abdalla Al-Zawi A
    Cureus; 2023 Sep; 15(9):e45462. PubMed ID: 37859908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer after Radiation Therapy in a Patient with Li-Fraumeni Syndrome: A Case Report.
    Yoon IN; Cha ES; Kim JH; Lee JE; Chung J
    Taehan Yongsang Uihakhoe Chi; 2022 Jan; 83(1):246-251. PubMed ID: 36237363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Four-Year-Old Female With a Rare P53 Gene Mutation Diagnosed With Li-Fraumeni Syndrome and Concomitant Metastatic Rhabdomyosarcoma: A Case Report.
    Donato UM; Donato S; Galligan A
    Cureus; 2022 Jul; 14(7):e27009. PubMed ID: 35989815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features of Breast Cancer in South Korean Patients with Germline
    Alyami H; Yoo TK; Cheun JH; Lee HB; Jung SM; Ryu JM; Bae SJ; Jeong J; Yoon CI; Ahn J; Paik PS; Cho MK; Park WC
    J Breast Cancer; 2021 Apr; 24(2):175-182. PubMed ID: 33818021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience.
    Murray KS; Spaliviero M; Tonorezos ES; Lacouture ME; Tap WD; Oeffinger KC; Vargas HA; Eastham JA
    Urology; 2018 Sep; 119():55-61. PubMed ID: 29935265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis and clinical outcome of a lung cancer patient with
    Yang D; Han X; Li D; Cui S; Liu S; Wu X; Dai Z
    Am J Transl Res; 2020; 12(10):6689-6693. PubMed ID: 33194065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome.
    Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A
    Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by
    Sandoval RL; Polidorio N; Leite ACR; Cartaxo M; Pisani JP; Quirino CV; Cezana L; Pereira NG; Pereira AAL; Rossi BM; Achatz MI
    Front Oncol; 2022; 12():836937. PubMed ID: 35371985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India.
    Tansir G; Rastogi S; Dubasi SK; Chitikela S; Reddy LR; Barwad A; Goyal A
    Ecancermedicalscience; 2023; 17():1550. PubMed ID: 37377684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.